The NIH NHLBI OM OA OFC ACQUISITIONS supports the National Heart, Lung, and Blood Institute’s mission to advance scientific innovation in diagnostics and biomedical instrumentation. Its core focus is procuring high-precision analytical laboratory instruments and specialized surgical/medical devices to enable rapid, accurate, and scalable diagnostic solutions—particularly for public health emergencies and translational research.
NIH Nhlbi Om Oa Ofc Acquisitions is a government agency with procurement activity across contracts, awards, and contractors.
Win Contracts from NIH Nhlbi Om Oa Ofc Acquisitions
Get AI-powered intelligence on NIH Nhlbi Om Oa Ofc Acquisitions procurement
AI-powered matching based on your business capabilities and past performance
Automated alerts when new opportunities are posted
Spending trends, top contractors, industry breakdown, and recent contract activity.
AI Mission Profile
The NIH NHLBI OM OA OFC ACQUISITIONS supports the National Heart, Lung, and Blood Institute’s mission to advance scientific innovation in diagnostics and biomedical instrumentation. Its core focus is procuring high-precision analytical laboratory instruments and specialized surgical/medical devices ...
The NIH NHLBI OM OA OFC ACQUISITIONS supports the National Heart, Lung, and Blood Institute’s mission to advance scientific innovation in diagnostics and biomedical instrumentation. Its core focus is procuring high-precision analytical laboratory instruments and specialized surgical/medical devices to enable rapid, accurate, and scalable diagnostic solutions—particularly for public health emergencies and translational research. Strategic priorities center on accelerating the development and deployment of point-of-care technologies, molecular diagnostics, and next-generation assay platforms that enhance early detection and monitoring of cardiopulmonary and infectious diseases. Key initiatives include the Rapid Acceleration of Diagnostics (RADx) program, which drives the procurement of novel, field-deployable testing systems with high sensitivity and affordability.
The agency primarily procures advanced analytical laboratory instruments and surgical/medical devices through non-set-aside solicitations, often leveraging research and development contracts, broad agency announcements, and other flexible acquisition vehicles suited for early-stage innovation. Contract structures emphasize performance-based outcomes, technical feasibility, and scalability, with a strong orientation toward transitioning laboratory prototypes into clinically viable tools.
Procurement activity is concentrated in NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and 339112 (Surgical and Medical Instrument Manufacturing), reflecting a deliberate focus on precision diagnostics and clinical deployment tools. The agency does not employ set-asides and engages vendors based on technical capability, regulatory readiness, and innovation potential rather than size or socioeconomic status. Relationships are typically project-driven, with an emphasis on rapid iteration and validation cycles.
Organized under the National Institutes of Health within the Department of Health and Human Services, this office operates as a specialized acquisition unit supporting NHLBI’s research infrastructure. It utilizes agile procurement mechanisms tailored to biomedical R&D, partnering with academic, commercial, and non-traditional innovators to bridge the gap between discovery and public health impact.
Recent NIH Nhlbi Om Oa Ofc Acquisitions Contracts
The latest contract opportunities posted by NIH Nhlbi Om Oa Ofc Acquisitions, including active solicitations and recent awards.
Senate-confirmed and senior-executive posts at NIH Nhlbi Om Oa Ofc Acquisitions and its sub-agencies, as published in the OPM Plum Book. These are leadership positions, not total employees.
Leadership posts
0
Filled
0
Vacant
0
Acting officials
0
No senior leadership posts resolved to this agency yet
Recent NIH Nhlbi Om Oa Ofc Acquisitions Contracts
The latest contract opportunities posted by this agency, including active solicitations and recent awards.